Interpretation of updates in the classification of cutaneous lymphomas in the 5th edition of the WHO Classification of Haematolymphoid Tumours (WHO-HAEM5)
Chinese Journal of Dermatology · 22.05.2026
DOI: 10.35541/cjd.20240605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Dermatology, online erschienen am 22.05.2026.
Abstract (Originalsprache)
摘要: 【摘要】 原发性皮肤淋巴瘤(PCL)是一组具有独特临床表现和组织学特征的异质性疾病,诊断和治疗存在一定挑战。2022年发布的第5版WHO造血与淋巴组织肿瘤分类(WHO-HAEM5)对PCL的分类进行了更新,涉及皮肤T细胞淋巴瘤(CTCL)和皮肤B细胞淋巴瘤的多种亚型。本次更新细化了对少见CTCL亚型的定义和归类,并将Sézary综合征从CTCL中移出,重新归类为成熟T细胞和自然杀伤细胞白血病。此外,PCL的分子遗传学研究取得新进展,反映在不同亚型的具体分类中。本文结合WHO-HAEM5的主要变化,对PCL分类更新内容进行解读,为临床实践提供参考。
Zitieren
APA
(2026). Interpretation of updates in the classification of cutaneous lymphomas in the 5th edition of the WHO Classification of Haematolymphoid Tumours (WHO-HAEM5). Chinese Journal of Dermatology. https://doi.org/10.35541/cjd.20240605
Vancouver
Interpretation of updates in the classification of cutaneous lymphomas in the 5th edition of the WHO Classification of Haematolymphoid Tumours (WHO-HAEM5). Chinese Journal of Dermatology. 2026. doi:10.35541/cjd.20240605
BibTeX
@article{euvimed2026,
title = {Interpretation of updates in the classification of cutaneous lymphomas in the 5th edition of the WHO Classification of Haematolymphoid Tumours (WHO-HAEM5)},
journal = {Chinese Journal of Dermatology},
year = {2026},
doi = {10.35541/cjd.20240605}
}
EUVIMED